Skip to main content
Log in

Comparison of four protocols for luteal phase support in frozen-thawed Embryo transfer cycles: a randomized clinical trial

  • Gynecologic Endocrinology and Reproductive Medicine
  • Published:
Archives of Gynecology and Obstetrics Aims and scope Submit manuscript

Abstract

Purpose

To compare the pregnancy outcomes between four regimens of luteal phase support (LPS), including vaginal progesterone, oral dydrogesterone, combination of oral dydrogesterone and gonadotropin releasing hormone analog (GnRH-α), and combination of oral dydrogesterone and human chorionic gonadotrophin (hCG), in Frozen-thawed Embryo Transfer (FET) cycles.

Methods

This randomized clinical trial was performed during a 6-month period, including candidates for FET. Patients were randomly assigned to four groups for LPS: 400 mg vaginal progesterone suppository twice daily, 10 mg oral dydrogesterone twice daily, 10 mg oral dydrogesterone twice daily combined with injection of 0.1 mg GnRH-α, and 10 mg oral dydrogesterone twice daily combined with injection of 1500 IU hCG. Primary endpoint included clinical pregnancy rate, ongoing pregnancy rate (OPR), and miscarriage rate (MR).

Results

A total of 400 FET cycles were analyzed. CPR was significantly lower in dydrogesterone group (9 %) when compared to vaginal progesterone (20 %), dydrogesterone and GnRH-α (25 %), and dydrogesterone and hCG (17 %). Logistic regression showed that only dydrogesterone group had significantly lower CPR in comparison with vaginal progesterone (OR = 0.39; p = 0.03), while it was comparable between other three groups. There were no significant difference between four groups regarding to OPR and MR.

Conclusion

Vaginal progesterone provides appropriate LPS. Yet, combination of oral dydrogesterone and GnRH-α or hCG can be more suitable option compared to vaginal progesterone for LPS in women with vaginal irritation or discharge at a lower cost.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Gardner DK, Weissman A, Howles CM, Shoham Z (2012) Textbook of assisted reproductive techniques. Clinical perspectives, vol 2, 4th edn. CRC Press, Florida

    Book  Google Scholar 

  2. Eftekhar M, Rahsepar M, Rahmani E (2013) Effect of progesterone supplementation on natural frozen-thawed Embryo transfer cycles: a randomized controlled trial. Int J Fertil Steril. 7(1):13

    PubMed  PubMed Central  Google Scholar 

  3. Ashrafi M, Jahangiri N, Hassani F, Akhoond MR, Madani T (2011) The factors affecting the outcome of frozen–thawed embryo transfer cycle. Taiwan J Obstet Gynecol 50(2):159–164

    Article  PubMed  Google Scholar 

  4. Veleva Z, Orava M, Nuojua-Huttunen S, Tapanainen JS, Martikainen H (2013) Factors affecting the outcome of frozen–thawed embryo transfer. Hum Reprod 28(9):2425–2431

    Article  PubMed  Google Scholar 

  5. Lan VTN, Tuan P, Canh L, Tuong H, Howles C (2008) Progesterone supplementation during cryopreserved embryo transfer cycles: efficacy and convenience of two vaginal formulations. Reprod Biomed Online 17(3):318–323

    Article  CAS  PubMed  Google Scholar 

  6. Chakravarty BN, Shirazee HH, Dam P, Goswami SK, Chatterjee R, Ghosh S (2005) Oral dydrogesterone versus intravaginal micronised progesterone as luteal phase support in assisted reproductive technology (ART) cycles: results of a randomised study. J Steroid Biochem Mol Biol 97(5):416–420

    Article  CAS  PubMed  Google Scholar 

  7. Shapiro DB, Pappadakis JA, Ellsworth NM, Hait HI, Nagy ZP (2014) Progesterone replacement with vaginal gel versus im injection: cycle and pregnancy outcomes in IVF patients receiving vitrified blastocysts. Hum Reprod 29(8):1706–1711

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Ganesh A, Chakravorty N, Mukherjee R, Goswami S, Chaudhury K, Chakravarty B (2011) Comparison of oral dydrogestrone with progesterone gel and micronized progesterone for luteal support in 1373 women undergoing in vitro fertilization: a randomized clinical study. Fertil Steril 95(6):1961–1965

    Article  CAS  PubMed  Google Scholar 

  9. Salehpour S, Tamimi M, Saharkhiz N (2013) Comparison of oral dydrogesterone with suppository vaginal progesterone for luteal-phase support in in vitro fertilization (IVF): a randomized clinical trial. Iran J Reprod Med 11(11):913

    CAS  PubMed  PubMed Central  Google Scholar 

  10. Patki A, Pawar VC (2007) Modulating fertility outcome in assisted reproductive technologies by the use of dydrogesterone. Gynecol Endocrinol 23(S1):68–72

    Article  CAS  PubMed  Google Scholar 

  11. Guo W, Chen X, Ye D, He Y, Li P, Niu J et al (2013) Effects of oral dydrogesterone on clinical outcomes of frozen-thawed embryo transfer cycles; Nan fang yi ke da xue xue bao. J South Med Univ 33(6):861–865

    Google Scholar 

  12. van der Linden M, Buckingham K, Farquhar C, Kremer JA, Metwally M (2011) Luteal phase support for assisted reproduction cycles. The Cochrane Library, London

    Google Scholar 

  13. Gordon JD, DiMattina M, Reh A, Botes A, Celia G, Payson M (2013) Utilization and success rates of unstimulated in vitro fertilization in the United States: an analysis of the Society for Assisted Reproductive Technology database. Fertil Steril 100(2):392–395

    Article  PubMed  Google Scholar 

  14. Nawroth F, Ludwig M (2005) What is the ‘ideal’duration of progesterone supplementation before the transfer of cryopreserved–thawed embryos in estrogen/progesterone replacement protocols? Hum Reprod 20(5):1127–1134

    Article  CAS  PubMed  Google Scholar 

  15. Shapiro BS, Daneshmand ST, Garner FC, Aguirre M, Ross R (2008) Contrasting patterns in in vitro fertilization pregnancy rates among fresh autologous, fresh oocyte donor, and cryopreserved cycles with the use of day 5 or day 6 blastocysts may reflect differences in embryo-endometrium synchrony. Fertil Steril 89(1):20–26

    Article  PubMed  Google Scholar 

  16. Cercas R, Villas C, Pons I, Braña C, Fernandez-Shaw S (2012) Vitrification can modify embryo cleavage stage after warming. Should we change endometrial preparation? J Assist Reprod Genet 29(12):1363–1368

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Lee VCY, Li RHW, Ng EHY, Yeung WSB, Ho PC (2013) Luteal phase support does not improve the clinical pregnancy rate of natural cycle frozen-thawed embryo transfer: a retrospective analysis. Eur J Obstet Gynecol Reprod Biol 169(1):50–53

    Article  PubMed  Google Scholar 

  18. Zhao Y, Brezina P, Hsu C-C, Garcia J, Brinsden PR, Wallach E (2011) In vitro fertilization: four decades of reflections and promises. Biochim Biophys Acta Gen Subj 1810(9):843–852

    Article  CAS  Google Scholar 

  19. Bjuresten K, Landgren B-M, Hovatta O, Stavreus-Evers A (2011) Luteal phase progesterone increases live birth rate after frozen embryo transfer. Fertil Steril 95(2):534–537

    Article  CAS  PubMed  Google Scholar 

  20. Vaisbuch E, Leong M, Shoham Z (2012) Progesterone support in IVF: is evidence-based medicine translated to clinical practice? A worldwide web-based survey. Reprod Biomed Online 25(2):139–145

    Article  CAS  PubMed  Google Scholar 

  21. Kyrou D, Kolibianakis E, Fatemi H, Tarlatzi T, Devroey P, Tarlatzis B (2011) Increased live birth rates with GnRH agonist addition for luteal support in ICSI/IVF cycles: a systematic review and meta-analysis. Hum Reprod Update 17(6):734–740

    Article  CAS  PubMed  Google Scholar 

  22. Pirard C, Donnez J, Loumaye E (2006) GnRH agonist as luteal phase support in assisted reproduction technique cycles: results of a pilot study. Hum Reprod 21(7):1894–1900

    Article  CAS  PubMed  Google Scholar 

  23. Tesarik J, Hazout A, Mendoza-Tesarik R, Mendoza N, Mendoza C (2006) Beneficial effect of luteal-phase GnRH agonist administration on embryo implantation after ICSI in both GnRH agonist-and antagonist-treated ovarian stimulation cycles. Hum Reprod 21(10):2572–2579

    Article  CAS  PubMed  Google Scholar 

  24. Ata B, Yakin K, Balaban B, Urman B (2008) GnRH agonist protocol administration in the luteal phase in ICSI–ET cycles stimulated with the long GnRH agonistprotocol: a randomized, controlled double blind study. Hum Reprod 23(3):668–673

    Article  CAS  PubMed  Google Scholar 

  25. Reshef E, Lei Z, Rao CV, Pridham D, Chegini N, Luborsky J (1990) The presence of gonadotropin receptors in nonpregnant human uterus, human placenta, fetal membranes, and decidua. J Clin Endocrinol Metab 70(2):421–430

    Article  CAS  PubMed  Google Scholar 

  26. Fujimoto A, Osuga Y, Fujiwara T, Yano T, Tsutsumi O, Momoeda M et al (2002) Human chorionic gonadotropin combined with progesterone for luteal support improves pregnancy rate in patients with low late-midluteal estradiol levels in IVF cycles. J Assist Reprod Genet 19(12):550–554

    Article  PubMed  PubMed Central  Google Scholar 

  27. Var T, Tonguc EA, Doğanay M, Gulerman C, Gungor T, Mollamahmutoglu L (2011) A comparison of the effects of three different luteal phase support protocols on in vitro fertilization outcomes: a randomized clinical trial. Fertil Steril 95(3):985–989

    Article  PubMed  Google Scholar 

  28. Bourdiec A, Bédard D, Rao C, Akoum A (2013) Human chorionic gonadotropin regulates endothelial cell responsiveness to interleukin 1 and amplifies the cytokine-mediated effect on cell proliferation, migration and the release of angiogenic factors. Am J Reprod Immunol 70(2):127–138

    Article  CAS  PubMed  Google Scholar 

  29. Cunningham FGLK, Bloom SL, Hauth JC, Rouse DJ, Spong CY (2010) Implantation, embryogenesis, and placental development: secretory or postovulatory endometrial phase. In: Cunningham FGLK, Bloom SL, Hauth JC, Rouse DJ, Spong CY (eds) Williams obstetrics. McGraw-Hill, New York, p 48

    Google Scholar 

  30. Kodaman PH, Taylor HS (2004) Hormonal regulation of implantation. Obstet Gynecol Clin North Am 31(4):745–766

    Article  PubMed  Google Scholar 

  31. van de Vijver A, Polyzos NP, Van Landuyt L, Mackens S, Stoop D, Camus M et al (2016) What is the optimal duration of progesterone administration before transferring a vitrified-warmed cleavage stage embryo? Randomized controlled trial. Hum Reprod 31(5):1097–1104

    Article  PubMed  Google Scholar 

  32. Casper RF, Yanushpolsky EH (2016) Optimal endometrial preparation for frozen embryo transfer cycles: window of implantation and progesterone support. Fertil Steril 105(4):867–872

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Parastoo Sohail.

Ethics declarations

Funding

This study was funded by granny from vice chancellor of research of Shiraz University of Medical Sciences (Grant No. 1376-52-21).

Conflict of interest

None of the authors have any conflict of interest to declare regarding the manuscript.

Ethical approval

All procedures performed in the current study were in accordance with the ethical standards of the Shiraz University of Medical Sciences and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

Informed consent

Informed consent was obtained from all individual participants included in the study.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Zarei, A., Sohail, P., Parsanezhad, M.E. et al. Comparison of four protocols for luteal phase support in frozen-thawed Embryo transfer cycles: a randomized clinical trial. Arch Gynecol Obstet 295, 239–246 (2017). https://doi.org/10.1007/s00404-016-4217-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00404-016-4217-4

Keywords

Navigation